产科风险评估:妊娠期疫苗研究选择标准的评价
为设计针对孕妇的疫苗试验,需量化不良妊娠结局的背景风险以区分于疫苗安全性评估。作者基于文献与指南综述,开发了逐步评估产科与母体风险因素的方法,并据此批判性审视母体疫苗研究的纳入与排除标准。该风险评估工具预期可辅助试验设计决策,如排除标准选择、受试者风险分层及干预孕周安排,并可用于分析时的数据分层。
要点
- 孕妇疫苗试验设计需量化不良妊娠结局的背景风险。
- 产科风险应基于既往与当前产科史及母体病史评估。
- 逐步评估法可辅助排除标准制定与受试者风险分层。
核心结论
- 产科风险评估有助于区分不良妊娠结局的背景风险与疫苗安全性评估。
- 基于文献与指南的逐步评估法可辅助母体疫苗试验设计决策。
研究设计与样本
- 基于已发表文献与指南的综述,开发逐步评估产科与母体风险因素的方法。
- 在母体疫苗研究纳入与排除标准设计的背景下批判性评估这些因素。
主要发现
- 产科风险量化基于既往和当前产科史及母体病史。
- 该评估可能辅助排除标准选择、高或低风险受试者亚组分类及干预孕周安排。
- 该工具还可用于研究分析时的数据分层。
关键数值与推荐
- GAIA项目已开发并发表妊娠期免疫安全评估的病例定义及数据收集、分析、评价指南。
临床怎么用
- 临床试验设计者可利用该风险评估工具决定排除标准与受试者风险分层。
- 可利用该工具在研究分析时进行数据分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccines designed for use in pregnancy and vaccine trials specifically involving pregnant women are rapidly expanding. One of the key challenges in designing maternal immunization trials is that developing exclusion criteria requires understanding and quantifying the background risk for adverse pregnancy outcomes in the pregnancy being studied, which can occur independent of any intervention and be unrelated to vaccine administration. The Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project has developed and published case definitions and guidelines for data collection, analysis, and evaluation of maternal immunization safety in trials involving pregnant women. Complementing this work, we sought to understand how to best assess obstetric risk of adverse outcomes and differentiate it from the assessment of vaccine safety. Quantification of obstetric risk is based on prior and current obstetric, and maternal medical history. We developed a step-wise approach to evaluate and quantify obstetric and maternal risk factors in pregnancy based on review of published literature and guidelines, and critically assessed these factors in the context of designing inclusion and exclusion criteria for maternal vaccine studies. We anticipate this risk assessment evaluation may assist clinical trialists with study design decisions, including selection of exclusion criteria for vaccine trials involving pregnant women, consideration of sub-group classification, such as high or low risk subjects, or schedule considerations, such as preferred trimester of gestation for an intervention during pregnancy. Additionally, this tool may be utilized in data stratification at time of study analyses.
引用
- Eckert LO, Jones CE, Kachikis A, et al. Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. Vaccine. 2020. PMID: 32448618. doi:10.1016/j.vaccine.2020.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。